Correlation Between NOVARTIS and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NOVARTIS and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NOVARTIS and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NOVARTIS CAP P and Pfizer Inc, you can compare the effects of market volatilities on NOVARTIS and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NOVARTIS with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of NOVARTIS and Pfizer.

Diversification Opportunities for NOVARTIS and Pfizer

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between NOVARTIS and Pfizer is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding NOVARTIS CAP P and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and NOVARTIS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NOVARTIS CAP P are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of NOVARTIS i.e., NOVARTIS and Pfizer go up and down completely randomly.

Pair Corralation between NOVARTIS and Pfizer

Assuming the 90 days trading horizon NOVARTIS CAP P is expected to generate 0.93 times more return on investment than Pfizer. However, NOVARTIS CAP P is 1.08 times less risky than Pfizer. It trades about 0.02 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.04 per unit of risk. If you would invest  8,221  in NOVARTIS CAP P on September 1, 2024 and sell it today you would earn a total of  58.00  from holding NOVARTIS CAP P or generate 0.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy44.44%
ValuesDaily Returns

NOVARTIS CAP P  vs.  Pfizer Inc

 Performance 
       Timeline  
NOVARTIS CAP P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NOVARTIS CAP P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for NOVARTIS CAP P investors.
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

NOVARTIS and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NOVARTIS and Pfizer

The main advantage of trading using opposite NOVARTIS and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NOVARTIS position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind NOVARTIS CAP P and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios